Literature DB >> 22738809

Epigenetics, sirtuins and osteoarthritis.

Odile Gabay1, Christelle Sanchez.   

Abstract

Epigenetics, modifications of the DNA other than changes on the DNA sequences, is frequently studied in cancer research and aging. DNA methylation, mi-RNA, and histones deacetylation are investigated in different pathologies, including inflammatory diseases and age-related diseases such as osteoarthritis (OA). In this review, we focus on the chromatin-modifying enzymes in arthritic pathologies, and more particularly on Sirtuins. We also review the role of Sirt1 in OA, which has been highlighted in recent publications, and examine the possible protective role Sirt1 could play in this disease. Moreover, we discuss the possible therapeutic target of such a protein, reviewing the potential inhibitors/activators of this enzyme and their properties.
Copyright © 2012 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738809     DOI: 10.1016/j.jbspin.2012.04.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  14 in total

1.  Aging Promotes Sirtuin 3-Dependent Cartilage Superoxide Dismutase 2 Acetylation and Osteoarthritis.

Authors:  Yao Fu; Michael Kinter; Joanna Hudson; Kenneth M Humphries; Rachel S Lane; Jeremy R White; Michael Hakim; Yong Pan; Eric Verdin; Timothy M Griffin
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

Review 2.  Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.

Authors:  Jingting Li; James Ohliger; Ming Pei
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 3.  Emerging roles for long noncoding RNAs in skeletal biology and disease.

Authors:  Nguyen P T Huynh; Britta A Anderson; Farshid Guilak; Audrey McAlinden
Journal:  Connect Tissue Res       Date:  2016-06-02       Impact factor: 3.417

Review 4.  Aging processes and the development of osteoarthritis.

Authors:  Richard F Loeser
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

5.  Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity.

Authors:  John R P Knight; Simon J Allison; Jo Milner
Journal:  Open Biol       Date:  2013-11-20       Impact factor: 6.411

6.  Hydroxytyrosol prevents increase of osteoarthritis markers in human chondrocytes treated with hydrogen peroxide or growth-related oncogene α.

Authors:  Annalisa Facchini; Silvia Cetrullo; Stefania D'Adamo; Serena Guidotti; Manuela Minguzzi; Andrea Facchini; Rosa Maria Borzì; Flavio Flamigni
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

7.  NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis.

Authors:  Siyoung Yang; Je-Hwang Ryu; Hwanhee Oh; Jimin Jeon; Ji-Sun Kwak; Jin-Hong Kim; Hyun Ah Kim; Churl-Hong Chun; Jang-Soo Chun
Journal:  Ann Rheum Dis       Date:  2013-12-17       Impact factor: 19.103

Review 8.  The age-related changes in cartilage and osteoarthritis.

Authors:  YongPing Li; XiaoChun Wei; JingMing Zhou; Lei Wei
Journal:  Biomed Res Int       Date:  2013-07-22       Impact factor: 3.411

9.  Resveratrol, a sirtuin 1 activator, increases IL-6 production by peripheral blood mononuclear cells of patients with knee osteoarthritis.

Authors:  Daniel Wendling; Wasim Abbas; Marie Godfrin-Valnet; Xavier Guillot; Kashif Aziz Khan; Jean-Pierre Cedoz; Lucile Baud; Clément Prati; Georges Herbein
Journal:  Clin Epigenetics       Date:  2013-07-11       Impact factor: 6.551

10.  Involvement of MicroRNA-210 Demethylation in Steroid-associated Osteonecrosis of the Femoral Head.

Authors:  Heng-feng Yuan; Von Roemeling Christina; Chang-an Guo; Yi-wei Chu; Rong-hua Liu; Zuo-qin Yan
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.